Endocrinology, Vol 133, 1895-1898, Copyright © 1993 by Endocrine Society

ARTICLES

Basic fibroblast growth factor selectively amplifies the functional state of neurons producing neuropeptide Y but not somatostatin in cultures of fetal brain cells: evidence for a cooperative interaction with insulin-like growth factor-I

A Barnea and G Cho
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas 75235.

The role of basic fibroblast growth factor (bFGF) in regulating the functional state of neuropeptide Y (NPY) neurons in the brain was investigated, using aggregate cultures, derived from 17-day-old fetal rat cortex maintained for 16 days in serum-free medium, as a model. The criterion for the functional state was NPY production in response to a 24-h exposure to forskolin + phorbol 12-myristate 13-acetate (For + PMA). bFGF (0.1 nM) induced a approximately 2-fold increase in NPY production under basal conditions as well as after For + PMA (p < 0.001 vs control). To address the possibility that bFGF may interact with other growth factors, we assessed the effect of bFGF in the presence of long R3-insulin-like growth factor-I (l-IGF-I; 1 nM) and found that NPY production in response to For + PMA was even greater than with bFGF alone (2-fold; p < 0.001); even though l-IGF-I by itself was ineffective; suggesting that bFGF is the driving force of this amplification. To assess the selectivity of this process, we evaluated SRIF production in response to For + PMA and found that it was not amplified by bFGF, l-IGF-I, or bFGF + l-IGF-I. These results are consistent with bFGF selectively amplifying the functional state of the cAMP and protein kinase C (PKC) pathways leading to increased NPY- production, with cooperative interaction(s) between bFGF and IGF-I, and with a role for bFGF and IGF-I in the developmental expression/survival of the NPY neurons.

This article has been cited by other articles:

				D. L. Miller, S. Ortega, O. Bashayan, R. Basch, and C. Basilico Compensation by Fibroblast Growth Factor 1 (FGF1) Does Not Account for the Mild Phenotypic Defects Observed in FGF2 Null Mice Mol. Cell. Biol., March 15, 2000; 20(6): 2260 - 2268. [Abstract] [Full Text]

				S. Ortega, M. Ittmann, S. H. Tsang, M. Ehrlich, and C. Basilico Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2 PNAS, May 12, 1998; 95(10): 5672 - 5677. [Abstract] [Full Text] [PDF]

				J. D. Browning, R. S. MacDonald, W. H. Thornton, and B. L. O'Dell Reduced Food Intake in Zinc Deficient Rats Is Normalized by Megestrol Acetate but not by Insulin-Like Growth Factor-I J. Nutr., January 1, 1998; 128(1): 136 - 142. [Abstract] [Full Text]

				A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin Biological Roles of Fibroblast Growth Factor-2 Endocr. Rev., February 1, 1997; 18(1): 26 - 45. [Abstract] [Full Text]